Dr. Brewitt Earns Elite Honor

Seattle Scientist Named As One of Fast Company Magazine's "Fast 50 Champions Of Innovation"

Dr. Barbara Brewitt's Ground Breaking Research on Human Growth Hormone Earns Elite Business Honor

Monday, February 16 – Barbara Brewitt, Ph.D. founder, CEO and Chief Scientific Officer at Seattle based Biomed Comm Inc., has been named as one of Fast Company magazine's third annual list of “Fast 50” innovators –individuals whose achievements have significantly advanced their companies or industries.

Selected by Fast Company editors, the Fast 50 includes executives, activists, marketers, designers, scientists, engineers and other leaders from a variety of backgrounds. Some are solo entrepreneurs and researchers. Others come from a wide range of organizations – from large corporations to start-ups.

“The Fast 50 are the idea elite of business; individuals with the vision and personal commitment to propel their companies and industries into the future,” said Fast Company editor-in-chief John Byrne.

Dr. Barbara Brewitt is recognized for her double blind, placebo-controlled clinical studies on human growth hormone and growth factors. Through these studies, she discovered that by simply enhancing the body's ability to communicate with itself on a cellular level, the body achieves optimal immune, nervous and hormonal health. By observing the body's natural responses, she created a system of cell-signal enhancer^® medicines that utilize diluted doses of a patented oral, safe Human Growth Hormone (hGH)& growth factors to provide effective health solutions at affordable prices that are accessible to the masses.

Building on those discoveries, Dr. Brewitt founded Biomed Comm^®, Inc., which provides a complete line of hGH based cell-signal enhancer^® medicines available over the counter. Biomed‘s medicines are uniquely positioned to take advantage of a multi-billion dollar market as they address a variety of issues ranging from PMS and stress to human-immunodeficiency syndrome and autism. Biomed has experienced nearly 300% growth in the mass markets over the past 2 years, leveraging sales relationships with major brick and mortar retailers such as GNC, and Wild Oats, as well as branded e-commerce players such as Costco.com, Drugstore.com, among others. Her groundbreaking approach has resulted in her being a frequent guest speaker and author of numerous articles on subjects ranging from child development to healthy aging, and applications of human growth hormone (hGH) to combinations of CSE^® growth factors for HIV and autism.

The Fast 50 will appear in the March issue of Fast Company, the nation's leading magazine for management innovators, hitting newsstands on February 18. The list includes 50 exceptional achievers selected from online submissions by Fast Company readers. This year's list was selected from more than 1,650 entries submitted by individuals in 30 countries and nearly every state in the union.

The complete list of the Fast 50 begins on page 79 of Fast Company. Profiles of the Fast 50, as well as all reader submissions, may be accessed online at the special Fast 50 Website at www.fastcompany.com/fast50

Founded in 1996 and published monthly, New York-based Fast Company ( www.fastcompany.com ) covers ideas, trends and individuals devoted to innovation and managing change in today's economy. The magazine is owned by Gruner + Jahr USA , one of the top-ranked magazine publishers in the U.S. , reaching one of the largest readerships in America . Gruner + Jahr USA also publishes Inc, Child, Family Circle, Fitness, Parents and YM.

Biomed Comm^®, Inc., a Seattle-based biotechnology company, is the leader in the field of homeopathic recombinant human growth hormone. BMC bridges the gap between the effectiveness of prescription recombinant human growth hormone and safe, non-toxic over-the-counter medicines. BMC's products support all aspects of “healthy aging,” perhaps the most prevalent health issue among consumers and the media in today's aging baby boomer population. BMC is poised to serve this growing market of people looking for anti-aging products, estimated to be a potential market size of $500 billion within this decade.